
ANTILYMPHOCYTE THERAPY IN KIDNEY TRANSPLANTATION: A PROSPECTIVE RANDOMIZED TRIAL OF FULL-DOSE RABBIT ANTI-HUMAN THYMOCYTE GLOBULIN (RATG) VERSUS LOW-DOSE RATG AND BASILIXIMAB
Author(s) -
Igor Codreanu,
Paolo Cravedi,
Piero Ruggenenti,
Giuseppe Remuzzi
Publication year - 2004
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200407271-00731
Subject(s) - basiliximab , medicine , adverse effect , anti thymocyte globulin , tolerability , immunosuppression , urology , transplantation , kidney transplantation , concomitant , azathioprine , discontinuation , surgery , gastroenterology , disease